Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-015949
Filing Date
2014-03-17
Accepted
2014-03-17 08:31:21
Documents
11
Period of Report
2014-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v371227_10q.htm 10-Q 428400
2 EXHIBIT 31.1 v371227_ex31-1.htm EX-31.1 10070
3 EXHIBIT 31.2 v371227_ex31-2.htm EX-31.2 10104
4 EXHIBIT 32.1 v371227_ex32-1.htm EX-32.1 4064
5 EXHIBIT 32.2 v371227_ex32-2.htm EX-32.2 4515
  Complete submission text file 0001144204-14-015949.txt   3662169

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lltp-20140131.xml EX-101.INS 496901
7 XBRL TAXONOMY EXTENSION SCHEMA lltp-20140131.xsd EX-101.SCH 29832
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lltp-20140131_cal.xml EX-101.CAL 35035
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lltp-20140131_def.xml EX-101.DEF 144386
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lltp-20140131_lab.xml EX-101.LAB 454736
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lltp-20140131_pre.xml EX-101.PRE 229566
Mailing Address 86 GLOUCESTER PLACE GROUND FLOOR SUITE LONDON X0 W1U 6HP
Business Address 86 GLOUCESTER PLACE GROUND FLOOR SUITE LONDON X0 W1U 6HP 44 (0) 203 617 8739
Lightlake Therapeutics Inc. (Filer) CIK: 0001385508 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-139915 | Film No.: 14696206
SIC: 1000 Metal Mining